VCYTVeracyte, Inc.

$44.28

What is the market doing?

What the tape says about VCYT

Veracyte, Inc. is +60% over the past year while the S&P 500 is +23%: 37 points ahead of the market.

+60%

1-year return · S&P 500 +23%

vs 200-day average
+7.1%

vs 200-day average · close to trend

RSI (14)
44

RSI (14) · neutral

Below its 52-week high
−26%

Below its 52-week high

2024-08-06$21.82 – $59.55 · dashed line: 200-day average2026-08-26
Details
Last close2026-08-26
$44.28
1 monthS&P 500 +3.7%
−24%
1 yearS&P 500 +23%
+60%
5 yearsS&P 500 +87%
+0.77%
vs 50-day average$49.93
−11%
52-week high
$59.55
52-week low
$27.37
Annualised volatility
59%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
−$1.1M
Calendar-year price return
YearReturn
2026 (year to date)+5.2%
2025+6.3%
2024+44%
2023+16%
2022−42%
2021−16%
2020+75%
2019+122%
2018+93%
2017−16%
Average return by calendar month, 2016–2026
MonthYearsPositiveAverage
Jan104 of 10+2.4%
Feb103 of 10−3.7%
Mar102 of 10−1.7%
Apr105 of 10−3.5%
May104 of 10+2.7%
Jun109 of 10+10%
Jul116 of 11+8.4%
Aug116 of 11+3.8%
Sep104 of 10−1.1%
Oct105 of 10+7.2%
Nov107 of 10+16%
Dec103 of 10−3.9%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.